D. E. Shaw & Co., Inc. Quotient LTD Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

Shares

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2020 Aug 14, 2020	SELL	$3.64 - $9.26 $155,544 - $395,698	-42,732 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$2.54 - $9.38 $215,082 - $794,279	-84,678 Reduced 66.46%	42,732 $169,000
Q4 2019 Feb 14, 2020	BUY	$7.07 - $9.51 $291,128 - $391,602	41,178 Added 47.75%	127,410 $1.21 Million
Q3 2019 Nov 14, 2019	BUY	$7.77 - $11.26 $497,163 - $720,471	63,985 Added 287.61%	86,232 $670,000
Q2 2019 Aug 14, 2019	SELL	$7.91 - $10.25 $622,572 - $806,746	-78,707 Reduced 77.96%	22,247 $208,000
Q1 2019 May 15, 2019	BUY	$6.0 - $11.07 $605,724 - $1.12 Million	100,954 New	100,954 $910,000

Others Institutions Holding QTNT

# of Institutions

1

Shares Held

1.71K

Call Options Held

0

Put Options Held

0

Brewin Dolphin LTD London, X0

1.71K
Shares

$68
0.0% of portfolio

About Quotient Ltd

Ticker QTNT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Description
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological di...

More about QTNT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.